Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Mouse monoclonal antibodies raised against human CD21.|
|Storage buffer||PBS with 4-5mg/ml BSA|
|Contains||0.02% sodium azide|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||0.5 ug/10^6 cells|
|Immunohistochemistry (Frozen) (IHC (F))||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 1 publications below|
MA5-17708 targets CD21/CR2 in FACS and IHC (F) applications and shows reactivity with Human samples.
The MA5-17708 immunogen is mouse monoclonal antibodies raised against human CD21.
This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Sclerosing angiomatoid nodular transformation of the spleen: report of five cases and review of literature.
MA5-17708 was used in immunohistochemistry to report on five cases of sclerosing angiomatoid nodular transformation of the spleen
|Wang HL,Li KW,Wang J||Chinese medical journal (125:2386)||2012|
CD21; Complement C3d receptor; complement component (3d/Epstein Barr virus) receptor 2; Complement receptor type 2; Cr2; EBV receptor; Epstein-Barr virus receptor
C3DR; CD21; CR; CR2; CVID7; SLEB9